Dr. Charles Schlesinger, the vice president of clinical development at Impladent, shared at the Chicago Dental Society 2026 Midwinter Meeting that bioactive crystal technology (BCT) offers predictable bone regeneration.
Impladent’s OsteoGen bone grafting materials are built on BCT and feature nonsintered, biomimetic calcium phosphate crystals that promote regenerative bone growth. The composition of BCT is like natural bone, offering a more favorable environment for regeneration.
Unlike OsteoGen, many other bone graft materials on the market are sintered ceramics. Sintering is a high-heat process that's used to manufacture bone graft materials as well as other dental prosthodontics. During sintering, particles fuse into dense ceramic structures but alter the material's biological behavior. Additionally, sintered materials often remain visible on radiographs indefinitely, making it difficult to assess true bone regeneration.
OsteoGen bone grafting materials are available in plug, strip, and block forms.
